Holen Sie sich die Stockscreener-App
1.13
0.00%
0.02
Schlusskurs vom Vortag:
$1.15
Offen:
$1.15
24-Stunden-Volumen:
56,465
Relative Volume:
0.16
Marktkapitalisierung:
$48.24M
Einnahmen:
$24.38M
Nettoeinkommen (Verlust:
$-53.95M
KGV:
-0.4575
EPS:
-2.47
Netto-Cashflow:
$-23.31M
1W Leistung:
+5.50%
1M Leistung:
+9.52%
6M Leistung:
-10.16%
1J Leistung:
-64.62%
1-Tages-Spanne:
$1.1297
$1.19
1-Wochen-Bereich:
$1.075
$1.22
52-Wochen-Spanne:
$0.50
$3.46
Elutia Inc Stock (ELUT) Company Profile
Firmenname
Elutia Inc
Sektor
Branche
Telefon
240-247-1143
Adresse
12510 PROSPERITY DRIVE, SILVER SPRING
Compare ELUT vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ELUT
Elutia Inc
|
1.1297 | 49.11M | 24.38M | -53.95M | -23.31M | -2.47 |
|
ABT
Abbott Laboratories
|
107.94 | 187.91B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
339.55 | 129.05B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
87.51 | 112.19B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
68.68 | 101.72B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
82.23 | 49.14B | 6.07B | 1.06B | 1.34B | 1.8063 |
Elutia Inc Stock (ELUT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-11-02 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-11-02 | Eingeleitet | Cowen | Outperform |
| 2020-11-02 | Eingeleitet | Piper Sandler | Overweight |
| 2020-11-02 | Eingeleitet | Truist | Buy |
Elutia Inc Aktie (ELUT) Neueste Nachrichten
Elutia Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Elutia grants 460,000 stock options to 3 new hires at $1.09 - Stock Titan
Elutia (ELUT) Q4 2025 Earnings Call Transcript - AOL.com
Elutia Q4 2025 slides: $88M sale funds pivot to breast reconstruction - Investing.com Australia
Elutia Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:ELUT) 2026-03-12 - Seeking Alpha
Elutia Reports Strong 2025 Financial Results, Advances NXT-41x for Breast Cancer Surgery, and Closes $88M BioEnvelope Sale to Boston Scientific - Minichart
Elutia Inc (ELUT) Q4 2025 Earnings Call Highlights: Revenue Growth and Strategic Moves Amid ... By GuruFocus - Investing.com Canada
Elutia Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Elutia Reports Fourth Quarter and Full Year 2025 Financial Results; Initiates NXT-41 Regulatory Process - Bitget
Earnings call transcript: Elutia Q4 2025 beats forecasts, stock steady By Investing.com - Investing.com Australia
Earnings call transcript: Elutia Q4 2025 beats forecasts, stock steady - Investing.com India
Elutia earnings beat by $1.60, revenue topped estimates - Investing.com Canada
Elutia reports $3.3M Q4 revenue, $70.8M net income on BioEnvelope sale; $44.4M year-end cash - TradingView
ELUTIA ($ELUT) Releases Q4 2025 Earnings, Stock Rises - Quiver Quantitative
Elutia Q4 revenue rises on higher cardiovascular product sales - TradingView
Elutia Inc. Adopts 2026 Inducement Award Plan and Files Form 8-K Disclosure - Minichart
Exploring Elutia's Earnings Expectations - Benzinga
Elutia Inc (ELUT) Q4 2025: Everything You Need To Know Ahead Of Earnings - GuruFocus
Elutia Adopts 2026 Inducement Equity Award Plan - TipRanks
Elutia Inc expected to post a loss of 14 cents a shareEarnings Preview - TradingView
Risks Report: Is Elutia Inc subject to activist investor interestMarket Rally & Accurate Entry/Exit Alerts - baoquankhu1.vn
Elutia Regains Full Nasdaq Compliance, Strengthening Listing Status - The Globe and Mail
Elutia (ELUT) Expected to Announce Earnings on Wednesday - MarketBeat
Elutia regains compliance with Nasdaq listing requirements - Investing.com Australia
Elutia regains compliance with Nasdaq listing requirements By Investing.com - Investing.com Canada
Elutia regains Nasdaq compliance after meeting minimum bid price and MVLS - TradingView
Elutia Regains Compliance with Nasdaq Listing Requirements - Bitget
Elutia (NASDAQ: ELUT) regains full Nasdaq listing compliance after bid price, value breach - Stock Titan
Elutia names Pete Ligotti chief commercial officer - Investing.com
Elutia Selects Pete Ligotti as CCO to Lead the Commercial Launch of NXT-41x and Transform Post-Mastectomy Care in the $1.5B U.S. Breast Surgery Market - Bitget
Elutia Selects Pete Ligotti as CCO to Lead the Commercial - GlobeNewswire
New Elutia CCO targets 15–20% infection rates in breast reconstruction - Stock Titan
ELUT Should I Buy - Intellectia AI
Elutia to Report Fourth Quarter 2025 Financial Results on Wednesday, March 11, 2026 - Bitget
ELUT SEC FilingsElutia Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
ELUT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Interview with the President and CEO: Elutia Inc. (NASDAQ:ELUT) - The Wall Street Transcript
Short Squeeze: What is the PEG ratio of Brookdale Senior Living IncStock Surge & Free Growth Oriented Trading Recommendations - baoquankhu1.vn
Where Purpose Meets Performance: Elutia Earns 2026 Great Place to Work Certification - HRTech Series
Where Purpose Meets Performance: Elutia Earns 2026 Great Place to Work Certification™ - The Manila Times
Targets Report: What is the Moat Score of Elutia IncJuly 2025 Earnings & Technical Confirmation Trade Alerts - baoquankhu1.vn
Alyeska discloses 3.18% Elutia (ELUT) stake in amended 13G - Stock Titan
Elutia Inc. (NASDAQ:ELUT) Surges 28% Yet Its Low P/S Is No Reason For Excitement - simplywall.st
Short Covering: Is Elutia Inc benefiting from innovation trendsJuly 2025 Big Picture & Community Verified Trade Signals - baoquankhu1.vn
What is Elutia Inc. s debt to equity ratioJuly 2025 Closing Moves & Safe Capital Growth Plans - mfd.ru
Knollwood discloses 6.3% Elutia Inc (NASDAQ: ELUT) stake - Stock Titan
CEO Moves: Is Elutia Inc benefiting from innovation trendsInsider Selling & Real-Time Volume Spike Alerts - baoquankhu1.vn
Will Elutia Inc. stock outperform value stocksGap Down & Technical Pattern Based Buy Signals - mfd.ru
Options Flow: Can Elutia Inc be recession proofPrice Action & Technical Confirmation Alerts - baoquankhu1.vn
Finanzdaten der Elutia Inc-Aktie (ELUT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.81%
0.75%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):